Compositions and methods for the prevention and treatment of anxiety conditions associated with the use of cannabis are disclosed herein. The medicinal compositions include cannabidiol or cannabidiolic acid and one or more of the following compounds: bergamottin or dihydroxybergamottin, phloretin or a phloretin glycoside, piperine, apigenin or an apigenin glycoside and ursolic acid.

The present application discloses natural compositions as medicaments and wellness products comprising of one or more cannabinoids and little or no THC comprised with other natural ingredients used for alleviating premenstrual, menstrual, and menopausal symptoms such as hot flashes, night sweats, mood changes, nausea, and Premenstrual Syndrome (PMS). The invention also contemplates methods of use of said compositions.

The present application discloses natural compositions as medicaments and wellness products comprising of one or more cannabinoids and little or no THC comprised with other natural ingredients used for alleviating premenstrual, menstrual, and menopausal symptoms such as hot flashes, night sweats, mood changes, nausea, and Premenstrual Syndrome (PMS). The invention also contemplates methods of use of said compositions.

The present invention provides a composition comprising a synergistic combination of melatonin, valerenic acid and carnosic acid. The composition may be used in the treatment and prevention of several different disorders including inflammatory conditions, sleep disorders and anxiety. The invention also relates to several dosage forms which are suitable for the delivery of the claimed composition to subjects in need of treatment therewith.

The present invention provides a composition comprising a synergistic combination of melatonin, valerenic acid and carnosic acid. The composition may be used in the treatment and prevention of several different disorders including inflammatory conditions, sleep disorders and anxiety. The invention also relates to several dosage forms which are suitable for the delivery of the claimed composition to subjects in need of treatment therewith.

An herbal formulation employing a plurality of ingredients extracted from a plurality of herbs for the regeneration of cardiomyocytes by reducing the after effects of myocardial infarction is disclosed. the herbal formulation made from one or all of the ingredients include Terminalia arjuna, Pashanbhedi (Bergenia lingulata), Jatamansi (Nardostachys jatamansi), Swarnabhasma (gold ultra fine powder), Gandhakrasayan, Trifala (Myrabilis), Commiphoramukul, Triphala (three myrobalans) andcalcined pearl shell powder (Mukthapisthi) in appropriate percentage by weight of the composition. According to the method of preparing the herbal formulation, the ingredients are purified by liquid solvent extraction and homogenization of herbal ingredients is achieved to attain a homogenous formulation. The formulation is prepared in any of the forms include but not limited to a gelatin capsule, a vegetarian capsule, a tablet, a liquid, a syrup, a dairy beverage and a snack bar.

An herbal formulation employing a plurality of ingredients extracted from a plurality of herbs for the regeneration of cardiomyocytes by reducing the after effects of myocardial infarction is disclosed. the herbal formulation made from one or all of the ingredients include Terminalia arjuna, Pashanbhedi (Bergenia lingulata), Jatamansi (Nardostachys jatamansi), Swarnabhasma (gold ultra fine powder), Gandhakrasayan, Trifala (Myrabilis), Commiphoramukul, Triphala (three myrobalans) andcalcined pearl shell powder (Mukthapisthi) in appropriate percentage by weight of the composition. According to the method of preparing the herbal formulation, the ingredients are purified by liquid solvent extraction and homogenization of herbal ingredients is achieved to attain a homogenous formulation. The formulation is prepared in any of the forms include but not limited to a gelatin capsule, a vegetarian capsule, a tablet, a liquid, a syrup, a dairy beverage and a snack bar.

An herbal formulation employing a plurality of ingredients extracted from a plurality of herbs for the regeneration of cardiomyocytes by reducing the after effects of myocardial infarction is disclosed. the herbal formulation made from one or all of the ingredients include Terminalia arjuna, Pashanbhedi (Bergenia lingulata), Jatamansi (Nardostachys jatamansi), Swarnabhasma (gold ultra fine powder), Gandhakrasayan, Trifala (Myrabilis), Commiphoramukul, Triphala (three myrobalans) andcalcined pearl shell powder (Mukthapisthi) in appropriate percentage by weight of the composition. According to the method of preparing the herbal formulation, the ingredients are purified by liquid solvent extraction and homogenization of herbal ingredients is achieved to attain a homogenous formulation. The formulation is prepared in any of the forms include but not limited to a gelatin capsule, a vegetarian capsule, a tablet, a liquid, a syrup, a dairy beverage and a snack bar.

Controlled-release therapeutic compositions including melatonin combined with sedative and/or analgesic ingredients are described. The compositions have a solid core including melatonin in an acidified polymeric matrix. A sedative ingredient such as GABA receptor agonist may also be in the acidified polymeric matrix. The composition may include an expedited release portion providing a burst release of active ingredients and a sustained release portion providing a sustained release of active ingredients.

Controlled-release therapeutic compositions including melatonin combined with sedative and/or analgesic ingredients are described. The compositions have a solid core including melatonin in an acidified polymeric matrix. A sedative ingredient such as GABA receptor agonist may also be in the acidified polymeric matrix. The composition may include an expedited release portion providing a burst release of active ingredients and a sustained release portion providing a sustained release of active ingredients.